Specialty Pharmacy

Top news of the day from across the health care landscape.

More than a half-billion people may have diabetes worldwide.

Intestinal microbiota may help predict rheumatoid arthritis symptom severity and frequency.

Stage 2 colon cancer patients administered adjuvant chemotherapy survived significantly longer than patients who did not.

Support groups and social networking help breast cancer patients manage emotions and stress.

United States Preventive Service Task Force screening guidelines for diabetes found to miss more than half of high-risk patients.

Burdock root, or gobo, associated with lower rates of colon cancer and colitis.

Chemotherapy drug may cause the loss of hearing during the treatment of testicular cancer.

Overexpression of Aurora Kinase could potentially inhibit a tumor suppressing gene.

Top articles of the week on Specialty Pharmacy Times.

Top news of the week from across the health care landscape.

Understanding cellular mechanism can improve treatment of chronic inflammatory disease.

Research could lead to improved personalized therapies for acute myeloid leukemia.

Selenocompounds were able to kill up to 80% of cancer cells in mice.

Specialty pharmacies need to maintain services that ensure optimal patient care and outcomes.

Patients treated for high cholesterol showed improved survival in bowel, breast, lung, and prostate cancers.

Researchers target causes of severe depression in MS patients.

Adlyxin is a once-daily injection that improves glycemic control in type 2 diabetes.

Top news of the day from across the health care landscape.

Analysis of HOX gene able to predict survival in ovarian cancer.

Participants who lost weight showed decreased expression of proteins that promote tumor-related angiogenesis.

Standardizing measurements across the lifecycle of a prescription will help specialty pharmacies demonstrate success.

Analysis finds health plans need to examine total treatment costs instead of just drug costs.

Vemurafenib is a multi-targeted kinase inhibitor originally approved to treat melanoma patients with a BRAF mutation.

New class of HIV medications called viral-entry inhibitors protect healthy cells from viral infection.

Top news of the day from across the health care landscape.

Veikira XR is a once-daily medication that treats hepatitis C genotype 1.

Compounds found in turmeric and milk thistle inhibit the spread of cancer cells.